Abstract
Neurogenic bladder that results from congenital spinal lesions is an important clinical entity. Unfortunately, the definition of neurogenic bladder is not straightforward. While the literature is plentiful, there are limited long-term outcomes that are known regarding the clinical or surgical management of these patients. There is even controversy regarding the workup and early infant treatment of neurogenic bladder. Without better disease definitions and phenotypes, the management remains non-standardized and the outcomes are not known. Appropriate understanding of the physical and clinical findings observed in this group of patients will help us to better define the risk of progression of disease. The following review and summary of the most recent literature will hopefully decrease some of the confusion and stimulate conversation about the creation and adoption of standards for workup and follow-up.
Similar content being viewed by others
Abbreviations
- NBD:
-
Neurogenic bladder dysfunction
- ESRD:
-
End-stage renal disease
- MMC:
-
Myelomeningocele
- TC:
-
Tethered spinal cord
- DSD:
-
Detrusor sphincter dyssynergia
- LPP:
-
Leak point pressure
- CIC:
-
Clean intermittent catheterization
- UTI:
-
Urinary tract infection
- UDS:
-
Urodynamic study
- VUR:
-
Vesicoureteral reflux
- ARM:
-
Anorectal malformation
References
Staskin DR et al. Bladder transection—a functional, neurophysiological, neuropharmacological and neuroanatomical study. Br J Urol. 1981;53(6):552–7.
Frimberger D, Cheng E, Kropp BP. The current management of the neurogenic bladder in children with spina bifida. Pediatr Clin N Am. 2012;59(4):757–67.
Kari JA. Neuropathic bladder as a cause of chronic renal failure in children in developing countries. Pediatr Nephrol. 2006;21(4):517–20.
Lambert SM. Transitional care in pediatric urology. Semin Pediatr Surg. 2015;24(2):73–8.
Verpoorten C, Buyse GM. The neurogenic bladder: medical treatment. Pediatr Nephrol. 2008;23(5):717–25.
Montagnino B. Posterior urethral valves: pathophysiology and clinical implications. ANNA J. 1994;21(1):26–30. 38; quiz 31–2.
Bauer SB. Neurogenic bladder: etiology and assessment. Pediatr Nephrol. 2008;23(4):541–51.
Larijani FJ et al. Preventing kidney injury in children with neurogenic bladder dysfunction. Int J Prev Med. 2013;4(12):1359–64.
de Jong TP et al. Treatment of the neurogenic bladder in spina bifida. Pediatr Nephrol. 2008;23(6):889–96.
Snow-Lisy, D.C., E.B. Yerkes, and E.Y. Cheng, Update on the urologic management of spina bifida from prenatal diagnosis to adulthood. J Urol, 2015.
Mourtzinos A, Stoffel JT. Management goals for the spina bifida neurogenic bladder: a review from infancy to adulthood. Urol Clin North Am. 2010;37(4):527–35.
Adzick NS, Walsh DS. Myelomeningocele: prenatal diagnosis, pathophysiology and management. Semin Pediatr Surg. 2003;12(3):168–74.
Ferrara P et al. Side-effects of oral or intravesical oxybutynin chloride in children with spina bifida. BJU Int. 2001;87(7):674–8.
Guzman L et al. Evaluation and management of children with sacral agenesis. Urology. 1983;22(5):506–10.
Hsieh MH et al. The effects of detethering on the urodynamics profile in children with a tethered cord. J Neurosurg. 2006;105(5 Suppl):391–5.
Joseph DB. The effect of medium-fill and slow-fill saline cystometry on detrusor pressure in infants and children with myelodysplasia. J Urol. 1992;147(2):444–6.
Kessler TM et al. Early proactive management improves upper urinary tract function and reduces the need for surgery in patients with myelomeningocele. Neurourol Urodyn. 2006;25(7):758–62.
Fox JA et al. Cystatin C as a marker of early renal insufficiency in children with congenital neuropathic bladder. J Urol. 2014;191(5 Suppl):1602–7.
Guerra L, Leonard M, Castagnetti M. Best practice in the assessment of bladder function in infants. Ther Adv Urol. 2014;6(4):148–64.
Lapides J et al. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol. 1972;107(3):458–61.
Martins G et al. Clean intermittent catheterization: educational booklet directed to caregivers of children with neurogenic bladder dysfunction. J Wound Ostomy Continence Nurs. 2009;36(5):545–9.
Woodward S, Steggal M, Tinhunu J. Clean intermittent self-catheterisation: improving quality of life. Br J Nurs. 2013;22(9):S20–S22-5.
Newman, D.K. and A.J. Wein, Managing and treating urinary incontinence. 2nd ed. 2009, Baltimore: Health Professions Press. xxiii, 630 p.
Newman DK, Willson MM. Review of intermittent catheterization and current best practices. Urol Nurs. 2011;31(1):12–28. 48; quiz 29.
Logan K et al. Patients’ experiences of learning clean intermittent self-catheterization: a qualitative study. J Adv Nurs. 2008;62(1):32–40.
Baskin LS, Kogan BA, Benard F. Treatment of infants with neurogenic bladder dysfunction using anticholinergic drugs and intermittent catheterisation. Br J Urol. 1990;66(5):532–4.
Kasabian NG et al. The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child. 1992;146(7):840–3.
Goessl C et al. Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia. Urology. 1998;51(1):94–8.
Aslan AR, Kogan BA. Conservative management in neurogenic bladder dysfunction. Curr Opin Urol. 2002;12(6):473–7.
Schulte-Baukloh H et al. Urodynamic effects of propiverine in children and adolescents with neurogenic bladder: results of a prospective long-term study. J Pediatr Urol. 2012;8(4):386–92.
Youdim K, Kogan BA. Preliminary study of the safety and efficacy of extended-release oxybutynin in children. Urology. 2002;59(3):428–32.
De Wachter S, Wyndaele JJ. Intravesical oxybutynin: a local anesthetic effect on bladder C afferents. J Urol. 2003;169(5):1892–5.
Nijman RJ et al. Tolterodine treatment for children with symptoms of urinary urge incontinence suggestive of detrusor overactivity: results from 2 randomized, placebo controlled trials. J Urol. 2005;173(4):1334–9.
Cameron, A.P., et al., The severity of bowel dysfunction in patients with neurogenic bladder. J Urol, 2015.
Lane MM et al. Reliability and validity of a modified Bristol stool form scale for children. J Pediatr. 2011;159(3):437–441 e1.
Halachmi S, Farhat WA. The impact of constipation on the urinary tract system. Int J Adolesc Med Health. 2008;20(1):17–22.
Bischoff A, Tovilla M. A practical approach to the management of pediatric fecal incontinence. Semin Pediatr Surg. 2010;19(2):154–9.
Compliance with Ethics Guidelines
Conflict of Interest
The authors declare that they have no competing interests.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Pediatric Bladder Dysfunction
Rights and permissions
About this article
Cite this article
Finkelstein, J.B., Creelman, L. & Alam, S. Neurogenic Bladder Secondary to Congenital Spinal Lesions. Curr Bladder Dysfunct Rep 10, 233–240 (2015). https://doi.org/10.1007/s11884-015-0307-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11884-015-0307-6